Chapter 2 Summary and Highlights
- Highlights of the Market for Epigenetic Therapeutics
Chapter 3 Market Overview and Definitions
Chapter 5 Market Breakdown by Product Type
- Introduction
- Prap Inhibitors
- Kinase Inhibitors
- Idh Inhibitors
- Hdac Inhibitors
- Dnmt Inhibitors
- Kmt Inhibitors
Chapter 6 Impact of Covid-19
- Introduction
- Impact of Covid-19 on the Medical Devices and Pharmaceutical Industries
- Decline/Delay in Elective Procedures
- Impact of Covid-19 on Medical Device and Pharmaceutical Product Segments
- Impact of Covid-19 on Epigenetic Therapeutics Markets
Chapter 7 Market Breakdown by Region
- Market Overview and Discussion
- North America
- Latin America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 8 Emerging/Upcoming Technologies
- Crispr
- Antibody Drug Conjugates
- Multitargeting Agents
Chapter 9 Competitive Landscape
- Industry Scenario
- Company Shares
Chapter 10 Patent Analysis
- Patent Analysis, by Manufacturer
Chapter 11 Pipeline Analysis
Chapter 12 Company Profiles
- Astrazeneca
- Bristol-Myers Squibb
- Clovis Oncology
- Gsk plc
- Incyte
- Ipsen
- Seagen
- Servier Laboratories, Ltd.
List of Tables
Summary Table: Global Epigenetic Therapeutics Market, by Product Type, Through 2028
Table 1: Global Population, Age 60 and Older, 2010-2050
Table 2: Incidence of Pancreas Cancer, 2020-2040
Table 3: Incidence of Trachea, Bronchus and Lung Cancer, 2020-2040
Table 4: Incidence of Melanoma Cancer, 2020-2040
Table 5: Incidence of Prostate Cancer, 2020-2040
Table 6: Incidence of Breast Cancer, 2020-2040
Table 7: Incidence of Kidney and Renal Pelvis Cancers, 2020-2040
Table 8: Incidence of Hodgkin Lymphoma Cancer, 2020-2040
Table 9: Incidence of Non-Hodgkin Lymphoma Cancer, 2020-2040
Table 10: Incidence of Multiple Myeloma and Immunoproliferative Diseases, 2020-2040
Table 11: Incidence of Leukemia Cancer, 2020-2040
Table 12: Global Epigenetic Therapeutics Market, by Product Type, Through 2028
Table 13: Global PRAP Inhibitors Market, by Region, Through 2028
Table 14: Global Kinase Inhibitors Market, by Region, Through 2028
Table 15: Global IDH Inhibitors Market, by Region, Through 2028
Table 16: Global HDAC Inhibitors Market, by Region, Through 2028
Table 17: Global DNMT Inhibitors Market, by Region, Through 2028
Table 18: Global KMT Inhibitors Market, by Region, Through 2028
Table 19: Global Epigenetic Therapeutics Market, by Region, Through 2028
Table 20: North American Epigenetic Therapeutics Market, by Country, Through 2028
Table 21: Latin American Epigenetic Therapeutics Market, by Country, Through 2028
Table 22: European Epigenetic Therapeutics Market, by Country, Through 2028
Table 23: Asia-Pacific Epigenetic Therapeutics Market, by Country, Through 2028
Table 24: RoW Epigenetic Therapeutics Market, Through 2028
Table 25: Patents on Epigenetic Drugs, 2015-April 2023
Table 26: Selected Manufacturer Patents on Epigenetic Drugs, 2015-April 2023
Table 27: Patents on HDAC Inhibitors, 2015-April 2023
Table 28: Selected Manufacturer Patents on HDAC inhibitors, 2015-April 2023
Table 29: Patents on Kinase inhibitors, 2015-April 2023
Table 30: Patents on Verinostat Drug, 2015-April 2023
Table 31: Selected Manufacturer Patents on Verinostat Drug, 2015-April 2023
Table 32: Patents on Romidepsin Drug, 2015-April 2023
Table 33: Selected Manufacturer Patents on Romidepsin Drug, 2015-April 2023
Table 34: Patents on Panobinostat Drug, 2015-April 2023
Table 35: Selected Manufacturer Patents on Panobinostat Drug, 2015-April 2023
Table 36: Patents on Belinostat, 2015-April 2023
Table 37: Selected Manufacturer Patents on Belinostat, 2015-April 2023
Table 38: Patents on Tucidinostat Drug, 2015-April 2023
Table 39: Selected Manufacturer Patents on Tucidinostat Drug, 2015-April 2023
Table 40: Patents on 5-Azacytidine Drug, 2015-April 2023
Table 41: Selected Manufacturer Patents on 5-Azacytidine Drug, 2015-April 2023
Table 42: Patents on 5-Aza-2’-Deoxycytidine Drug, 2015-April 2023
Table 43: Selected Manufacturer Patents on 5-Aza-2’-Deoxycytidine Drug, 2015-April 2023
Table 44: Patents on Pinometostat Drug, 2015-April 2023
Table 45: Selected Manufacturer Patents on Pinometostat Drug, 2015-April 2023
Table 46: Patents on Ruxolitinib Drug, 2015-April 2023
Table 47: Selected Manufacturer Patents on Ruxolitinib Drug, 2015-April 2023
Table 48: Patents on AZD1152 Drug, 2015-April 2023
Table 49: Selected Manufacturer Patents on AZD1152 Drug, 2015-April 2023
Table 50: Patents on Olaparib Drug, 2015-April 2023
Table 51: Selected Manufacturer Patents on Olaparib Drug, 2015-April 2023
Table 52: Patents on Veliparib Drug, 2015-April 2023
Table 53: Selected Manufacturer Patents on Veliparib Drug, 2015-April 2023
Table 54: Patents on Niraparib Drug, 2015-April 2023
Table 55: Selected Manufacturer Patents on Niraparib Drug, 2015-April 2023
Table 56: Patents on Rucaparib Drug, 2015-April 2023
Table 57: Selected Manufacturer Patents on Rucaparib Drug, 2015-April 2023
Table 58: Patents on Talazoparib Drug, 2015-April 2023
Table 59: Selected Manufacturer Patents on Talazoparib Drug, 2015-April 2023
Table 60: Selected Kinase Inhibitors in Clinical Trials, as of 2023
Table 61: Selected Olaparib Inhibitors in Clinical Trials, as of 2023
Table 62: Selected Romidepsin Inhibitors in Clinical Trials, as of 2023
Table 63: Selected Ruxolitinib Inhibitors in Clinical Trials, as of 2023
Table 64: AstraZeneca: Company Annual Revenue, 2019-2022
Table 65: AstraZeneca: Annual Revenue, by Product, 2022
Table 66: Bristol-Myers Squibb: Company Annual Revenue, 2019-2022
Table 67: Clovis Oncology: Revenue, 2019-2021
Table 68: GSK: Company Annual Revenue, 2019-2022
Table 69: GSK: Annual Revenue, by Product, 2022
Table 70: Incyte: Company Annual Revenue, 2019-2021
Table 71: Incyte: Product Revenue, 2019-2021
Table 72: Ipsen: Sales Revenue, 2021 and 2022
Table 73: Ipsen: Sales Revenue, by Segment, 2021 and 2022
Table 74: Ipsen: Sales Revenue, by Region, 2021 and 2022
Table 75: Seagen: Company Annual Revenue, 2019-2021
Table 76: Acronyms Used in this Report
List of Figures
Summary Figure A: Global Epigenetic Therapeutics Market, by Product Type, 2019-2028
Summary Figure B: Global Epigenetic Therapeutics Market Share, by Product Type, 2022
Figure 1: Global Epigenetic Therapeutics Market, by Product, 2020-2028
Figure 2: Global Epigenetic Therapeutics Market Share, by Product, 2022
Figure 3: Global PRAP Inhibitors Market, by Region, 2020-2028
Figure 4: Global PRAP Inhibitors Market Share, by Region, 2022
Figure 5: Global Kinase Inhibitors Market, by Region, 2020-2028
Figure 6: Global Kinase Inhibitors Market Share, by Region, 2022
Figure 7: Global IDH Inhibitors Market, by Region, 2020-2028
Figure 8: Global IDH Inhibitors Market Share, by Region, 2022
Figure 9: Global HDAC Inhibitors Market, by Region, 2020-2028
Figure 10: Global HDAC Inhibitors Market Share, by Region, 2022
Figure 11: Global DNMT Inhibitors Market, by Region, 2020-2028
Figure 12: Global DNMT Inhibitors Market Share, by Region, 2022
Figure 13: Global KMT Inhibitors Market, by Region, 2020-2028
Figure 14: Global KMT Inhibitors Market Share, by Region, 2022
Figure 15: Global Epigenetic Therapeutics Market Share, by Region, 2022
Figure 16: North American Epigenetic Therapeutics Market Share, by Country, 2022
Figure 17: Latin American Epigenetic Therapeutics Market Share, by Country, 2022
Figure 18: European Epigenetic Therapeutics Market Share, by Country, 2022
Figure 19: Asia-Pacific Epigenetic Therapeutics Market Share, by Country, 2022
Figure 20: Global Epigenetic Therapeutics Market Share, by Company, 2022
Figure 21: Global PRAP Inhibitors Market Share, by Company, 2022
Figure 22: Global Kinase Inhibitors Market Share, by Company, 2022
Figure 23: Global IDH Inhibitors Market Share, by Company, 2022
Figure 24: Global HDAC Inhibitors Market Share, by Company, 2022
Figure 25: Global DNMT Inhibitors Market Share, by Company, 2022
Figure 26: Global KMT Inhibitors Market Share, by Company, 2022
Figure 27: AstraZeneca: Sales Share, by Product, 2022
Figure 28: AstraZeneca: Sales Share, by Region, 2022
Figure 29: Bristol-Myers Squibb: Sales Share, by Region, 2022
Figure 30: GSK: Revenue Share, by Product, 2022
Figure 31: GSK: Sales Share, by Region, 2022
Figure 32: Ipsen: Sales Revenue Share, by Segment, 2022
Figure 33: Ipsen: Sales Revenue Share, by Region 2022
